Overview of the trastuzumab (Herceptin) anti-HER2 monoclonal antibody clinical program in HER2-overexpressing metastatic breast cancer. Herceptin Multinational Investigator Study Group
(Q33730978)
scientific article
scientific article
Language:
| (P31) |
(Q13442814)
(Q7318358)
|
||||||||
| (P304) |
71-77
|
||||||||
| (P433) |
4 Suppl 12
|
||||||||
| (P478) |
26
|
||||||||
| (P577) |
Sunday, August 1, 1999
|
||||||||
| (P921) |
(Q61643320)
(Q79460)
(Q412616)
(Q422248)
|
||||||||
| (P1433) |
(Q14330412)
|
||||||||
| (P1476) |
"Overview of the trastuzumab (Herceptin) anti-HER2 monoclonal antibody clinical program in HER2-overexpressing metastatic breast cancer. Herceptin Multinational Investigator Study Group" (language: en)
|
||||||||
| (P2093) |
S Shak
|